01 1Wuxi Fortune Pharmaceutical
01 1TACROLIMUS
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-08-26
Pay. Date : 2025-06-09
DMF Number : 39816
Submission : 2024-06-25
Status : Active
Type : II
20
Wuxi Fortune Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS, with a corresponding US DMF Number 39816.
Remarkably, this DMF maintains an Active status since its submission on June 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 26, 2025, and payment made on June 09, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
